BIO SmartBrief Latest Industry News

Latest News

UPDATE 2-ARCA gets fast-track status for heart drug, shares soar

Reuters | 10 hours 20 minutes ago

Nov 23 (Reuters) - ARCA biopharma Inc (ABIO.O) said U.S. health regulators granted a fast-track designation for its experimental drug, Gencaro, to treat chronic heart failure, sending its shares up as much as 81 percent.... (more)

Pfizer told to pay $28 mln damages in Prempro case

Reuters | 10 hours 24 minutes ago

NEW YORK, Nov 23 (Reuters) - A Philadelphia jury on Monday ordered Pfizer Inc (PFE.N) to pay $28 million in punitive damages to a breast cancer survivor who had used the company's hormone replacement drugs for 11 years.... (more)

$75M verdict unsealed in Prempro-cancer case

Fort Worth Star-Telegram (Texas) | 10 hours 57 minutes ago

The Associated Press PHILADELPHIA ? A jury in Philadelphia has ordered Wyeth Pharmaceuticals to pay a woman $75 million in punitive damages after finding a link between her breast cancer and a hormone-replacement drug.... (more)

Jury awards $75M in punitive damages to Illinois woman in Prempro cancer case

Sun (Baltimore), The | 10 hours 59 minutes ago

A jury in Philadelphia has ordered Wyeth Pharmaceuticals to pay a woman $75 million in punitive damages after finding a link between her breast cancer and a hormone-replacement drug.... (more)

Vaccines on horizon for AIDS, Alzheimer's, herpes

Yahoo! | 11 hours 27 minutes ago

MARIETTA, Pa. ? Malaria. Tuberculosis. Alzheimer's disease. AIDS. Pandemic flu. Genital herpes. Urinary tract infections. Grass allergies. Traveler's diarrhea. You name it, the pharmaceutical industry is working on a vaccine to prevent it.... (more)

Oncolytics completes $12.8M stock and warrant sale

Seattle Times, The | 11 hours 29 minutes ago

Canadian drug developer Oncolytics Biotech Inc. said Monday it raised $12.8 million through a sale of stock and options.... (more)

European Medicines Agency advisory committee gives 'negative opinion' of expanded use of Erbitux

Drug Store News | 11 hours 30 minutes ago

By Alaric DeArmentDARMSTADT, Germany (Nov. 23) An advisory committee in Europe has given a thumbs-down to efforts by Merck KGaA to gain approval for an additional use of a cancer drug.... (more)

< Prev 1 2 3 4 5 6 7 8 9 ... Next >

255 Stories | RSS Feed

Sign up for BIO SmartBrief

Designed specifically for biotechnology industry professionals like you, BIO SmartBrief is a FREE daily e-mail newsletter. It provides the latest news and information you need to stay informed about important biotech issues. Learn more